Trade Galera Therapeutics, Inc. - GRTX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0190 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.1855 |
| Open | 0.1645 |
| 1-Year Change | -93.94% |
| Day's Range | 0.1567 - 0.1772 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2024 | 0.1745 | 0.0075 | 4.49% | 0.1670 | 0.1775 | 0.1545 |
| Apr 23, 2024 | 0.1855 | 0.0010 | 0.54% | 0.1845 | 0.1915 | 0.1772 |
| Apr 22, 2024 | 0.1853 | 0.0134 | 7.80% | 0.1719 | 0.1900 | 0.1702 |
| Apr 19, 2024 | 0.1785 | -0.0005 | -0.28% | 0.1790 | 0.1846 | 0.1750 |
| Apr 18, 2024 | 0.1757 | -0.0261 | -12.93% | 0.2018 | 0.2019 | 0.1655 |
| Apr 17, 2024 | 0.1929 | 0.0016 | 0.84% | 0.1913 | 0.2275 | 0.1703 |
| Apr 16, 2024 | 0.1645 | 0.0300 | 22.30% | 0.1345 | 0.1645 | 0.1345 |
| Apr 15, 2024 | 0.1475 | -0.0061 | -3.97% | 0.1536 | 0.1558 | 0.1452 |
| Apr 12, 2024 | 0.1533 | 0.0035 | 2.34% | 0.1498 | 0.1546 | 0.1498 |
| Apr 11, 2024 | 0.1544 | 0.0014 | 0.92% | 0.1530 | 0.1548 | 0.1479 |
| Apr 10, 2024 | 0.1546 | -0.0018 | -1.15% | 0.1564 | 0.1564 | 0.1514 |
| Apr 9, 2024 | 0.1576 | 0.0031 | 2.01% | 0.1545 | 0.1577 | 0.1495 |
| Apr 8, 2024 | 0.1546 | 0.0041 | 2.72% | 0.1505 | 0.1615 | 0.1485 |
| Apr 5, 2024 | 0.1575 | 0.0030 | 1.94% | 0.1545 | 0.1578 | 0.1495 |
| Apr 4, 2024 | 0.1544 | 0.0098 | 6.78% | 0.1446 | 0.1582 | 0.1446 |
| Apr 3, 2024 | 0.1461 | -0.0029 | -1.95% | 0.1490 | 0.1515 | 0.1440 |
| Apr 2, 2024 | 0.1422 | -0.0143 | -9.14% | 0.1565 | 0.1613 | 0.1415 |
| Apr 1, 2024 | 0.1591 | -0.0324 | -16.92% | 0.1915 | 0.1915 | 0.1470 |
| Mar 28, 2024 | 0.1324 | -0.0191 | -12.61% | 0.1515 | 0.1785 | 0.1265 |
| Mar 27, 2024 | 0.1470 | -0.0250 | -14.53% | 0.1720 | 0.1720 | 0.1445 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Galera Therapeutics, Inc. Company profile
About Galera Therapeutics Inc
Galera Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is focused on developing and commercializing a pipeline of therapeutics to transform radiotherapy in cancer. The Company's lead product candidate, avasopasem manganese (GC4419), is a potent and selective small molecule dismutase mimetic, which is developed for the reduction of severe oral mucositis (SOM). It is also developing a second dismutase mimetic product candidate, GC4711, to increase the anti-cancer efficacy of stereotactic body radiation therapy (SBRT). It is evaluating GC4419 in a Phase III registrational trial (ROMAN trial) to reduce the incidence and severity of SOM induced by radiotherapy in patients with head and neck cancer (HNC), its lead indication. The Company is also evaluating GC4711 in combination with SBRT in a Phase I/II safety and anti-cancer efficacy trial in non-small cell lung cancer and a Phase IIb trial of GC4711 in combination with SBRT in patients with pancreatic cancer.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Galera Therapeutics Inc revenues was not reported. Net loss increased 9% to $80.5M. Higher net loss reflects General and administrative - Balancing increase of 32% to $16.6M (expense), Interest expense increase of 47% to $7.2M (expense), Stock-based Compensation in SGA increase of 40% to $4.3M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$2.98 to -$3.12.
| Industry: | Bio Therapeutic Drugs |
45 Liberty Blvd.
Suite 230
MALVERN
PENNSYLVANIA 19355
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com